These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 31088844)
1. A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients. Cursons J; Souza-Fonseca-Guimaraes F; Foroutan M; Anderson A; Hollande F; Hediyeh-Zadeh S; Behren A; Huntington ND; Davis MJ Cancer Immunol Res; 2019 Jul; 7(7):1162-1174. PubMed ID: 31088844 [TBL] [Abstract][Full Text] [Related]
2. Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden. Lin J; Lin Y; Huang Z; Li X Comput Math Methods Med; 2020; 2020():8836493. PubMed ID: 33273963 [TBL] [Abstract][Full Text] [Related]
3. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response. Li S; Zhao J; Wang G; Yao Q; Leng Z; Liu Q; Jiang J; Wang W Arch Dermatol Res; 2024 May; 316(6):262. PubMed ID: 38795156 [TBL] [Abstract][Full Text] [Related]
4. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature. Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392 [TBL] [Abstract][Full Text] [Related]
5. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment. Han W; Huang B; Zhao XY; Shen GL Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786 [TBL] [Abstract][Full Text] [Related]
6. Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology. Failmezger H; Muralidhar S; Rullan A; de Andrea CE; Sahai E; Yuan Y Cancer Res; 2020 Mar; 80(5):1199-1209. PubMed ID: 31874858 [TBL] [Abstract][Full Text] [Related]
7. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk. Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464 [TBL] [Abstract][Full Text] [Related]
8. Discovery of specialized NK cell populations infiltrating human melanoma metastases. de Andrade LF; Lu Y; Luoma A; Ito Y; Pan D; Pyrdol JW; Yoon CH; Yuan GC; Wucherpfennig KW JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31801909 [TBL] [Abstract][Full Text] [Related]
9. Transcriptome Analysis of Tumor-Infiltrating Lymphocytes Identifies NK Cell Gene Signatures Associated With Lymphocyte Infiltration and Survival in Soft Tissue Sarcomas. Judge SJ; Bloomstein JD; Sholevar CJ; Darrow MA; Stoffel KM; Vick LV; Dunai C; Cruz SM; Razmara AM; Monjazeb AM; Rebhun RB; Murphy WJ; Canter RJ Front Immunol; 2022; 13():893177. PubMed ID: 35874727 [TBL] [Abstract][Full Text] [Related]
10. Isolation and Phenotypic Characterization of Tumor-Infiltrating NK Cells in Skin Carcinoma. Arjmand B; Hamidpour SK; Tayanloo-Beik A; Arjmand R; Rezaei-Tavirani M; Aghayan H; Rajaeinejad M; Larijani B Methods Mol Biol; 2024; 2849():215-226. PubMed ID: 38329617 [TBL] [Abstract][Full Text] [Related]
11. Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity. Ni J; Wang X; Stojanovic A; Zhang Q; Wincher M; Bühler L; Arnold A; Correia MP; Winkler M; Koch PS; Sexl V; Höfer T; Cerwenka A Immunity; 2020 Jun; 52(6):1075-1087.e8. PubMed ID: 32445619 [TBL] [Abstract][Full Text] [Related]
12. Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients. Kasanen H; Hernberg M; Mäkelä S; Brück O; Juteau S; Kohtamäki L; Ilander M; Mustjoki S; Kreutzman A Cancer Immunol Immunother; 2020 May; 69(5):717-730. PubMed ID: 32036449 [TBL] [Abstract][Full Text] [Related]
13. Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors. Davis-Marcisak EF; Fitzgerald AA; Kessler MD; Danilova L; Jaffee EM; Zaidi N; Weiner LM; Fertig EJ Genome Med; 2021 Aug; 13(1):129. PubMed ID: 34376232 [TBL] [Abstract][Full Text] [Related]
14. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma. Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398 [TBL] [Abstract][Full Text] [Related]
15. A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis. Zhao Y; Schaafsma E; Gorlov IP; Hernando E; Thomas NE; Shen R; Turk MJ; Berwick M; Amos CI; Cheng C Mol Cancer Res; 2019 Jan; 17(1):109-119. PubMed ID: 30171176 [TBL] [Abstract][Full Text] [Related]
16. A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma. Sun Y; Sedgwick AJ; Palarasah Y; Mangiola S; Barrow AD Front Immunol; 2021; 12():668391. PubMed ID: 34539622 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of B cells in cutaneous melanoma. Selitsky SR; Mose LE; Smith CC; Chai S; Hoadley KA; Dittmer DP; Moschos SJ; Parker JS; Vincent BG Genome Med; 2019 May; 11(1):36. PubMed ID: 31138334 [TBL] [Abstract][Full Text] [Related]
18. Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature. Yang Y; Long X; Li G; Yu X; Liu Y; Li K; Tian X Bioengineered; 2021 Dec; 12(1):1803-1812. PubMed ID: 34047683 [TBL] [Abstract][Full Text] [Related]
19. Development and Validation of the B Cell-Associated Fc Receptor-like Molecule-Based Prognostic Signature in Skin Cutaneous Melanoma. Liu Y; Chen Y; Hu X; Meng J; Li X Biomed Res Int; 2020; 2020():8509805. PubMed ID: 32908921 [TBL] [Abstract][Full Text] [Related]